...
首页> 外文期刊>Acta Obstetricia et Gynecologica Scandinavica: Official Publication of the Nordisk Forening for Obstetrik och Gynekologi >Quality of life in patients with endometriosis and the effect of pertubation with lidocaine-a randomized controlled trial
【24h】

Quality of life in patients with endometriosis and the effect of pertubation with lidocaine-a randomized controlled trial

机译:子宫内膜异位症患者的生活质量和利多卡因摄动的影响-一项随机对照试验

获取原文
获取原文并翻译 | 示例

摘要

Objective Pertubation with lidocaine has been shown to reduce pain (on a VAS-scale) in women with endometriosis. A clinical study was performed to evaluate the effect of lidocaine pertubations on quality of life. Design Double-blind, randomized and controlled trial. Setting Three outpatient units in Stockholm, Sweden. Population Eligible patients had endometriosis with dysmenorrhoic pain >VAS 50 mm. Methods The patients were randomized to pre-ovulatory pertubations with lidocaine (n = 24) or placebo (n = 18) during three consecutive menstrual cycles. The procedure comprised passing the solution through the uterus and the Fallopian tubes via an intracervical balloon catheter. The effect was evaluated with the validated Endometriosis Health Profile-30 questionnaire before and after treatments. Main outcome measures Changes in scores at six and 12 months from baseline were compared between the groups with the Mann-Whitney U-test. Results After 6 months there was a significant difference between the lidocaine (n = 19) and the placebo (n = 16) groups for the dimension social support (median-18.8 vs.-6.3, p = 0.034), whereas there were no significant differences for the other dimensions after 6 or 12 months. The mean changes in the lidocaine group were above the minimal important difference levels in eight of 12 measurements of quality of life dimensions compared with two of 12 in the placebo group. Conclusions This clinical trial indicates that pertubations with lidocaine might improve the social support dimension of quality of life in patients with endometriosis.
机译:客观研究已证明,利多卡因插管可减轻子宫内膜异位症患者的疼痛(按VAS评分)。进行了一项临床研究,以评估利多卡因插管对生活质量的影响。设计双盲,随机和对照试验。在瑞典斯德哥尔摩设置三个门诊部。符合条件的患者子宫内膜异位症伴痛经痛> VAS 50 mm。方法在连续的三个月经周期中,患者随机接受利多卡因(n = 24)或安慰剂(n = 18)排卵前插管。该过程包括使溶液通过子宫颈球囊导管通过子宫和输卵管。在治疗前后用经验证的子宫内膜异位症健康状况30问卷评估疗效。主要结局指标用Mann-Whitney U检验比较了两组在基线水平起六个月和十二个月的得分变化。结果6个月后,利多卡因组(n = 19)和安慰剂组(n = 16)在社会支持方面存在显着差异(中位数18.8 vs.-6.3,p = 0.034),而无显着性差异。 6或12个月后其他尺寸的差异。利多卡因组的平均变化在12种生活质量量度测量中有8种高于最小重要差异水平,而安慰剂组为12种中的2种。结论该临床试验表明,利多卡因的插管可能会改善子宫内膜异位症患者生活质量的社会支持维度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号